Why Attend the 11th Microbiome Movement USA Summit?
Designed for leaders across discovery, development, clinical, regulatory, manufacturing, data science, and executive functions, the 11th Microbiome Movement USA Summit is the industry's leading forum for advancing microbiome innovation.
Join peers from across the ecosystem to explore the latest scientific breakthroughs, clinical and commercial strategies, regulatory developments, manufacturing solutions, and data-driven approaches shaping the future of microbiome therapeutics, consumer health products, and live biotherapeutics.
Connect with decision-makers, benchmark against industry leaders, and gain practical insights to accelerate programme success from research through commercialization.
Drive Strategic Growth in a Revitalized Microbiome Market
The microbiome sector has entered a defining period where scientific promise alone is no longer enough. Organizations must balance clinical advancement, manufacturing scalability, regulatory progress, and commercial strategy to attract investment and maintain competitive advantage.
The 11th Microbiome Movement USA Summit brings together the executives leading the industry's most clinically validated and commercially successful programmes, enabling you to benchmark your strategy against peers, understand where investors are allocating capital, and identify the business models most likely to support sustainable growth in an evolving market.
Who Should Attend?
- Chief Executive Officers
- Chief Scientific Officers
- Chief Medical Officers
- Chief Operating Officers
- Founder & President
Why Attend?
Join fellow executive leaders to discover how organizations are:
- Navigating a changing investment landscape through clinically validated and commercially viable microbiome programs, enabling more sustainable business growth
- Balancing therapeutic and direct-to-consumer strategies to diversify revenue streams and reduce development risk
- Expanding into new disease indications including oncology, women's health, inflammatory disease and neurology, unlocking broader market opportunities
- Building investor confidence through stronger clinical evidence, differentiated mechanisms of action and scalable development models
- Learning from both clinical successes and setbacks to inform smarter portfolio and pipeline decisions
- Connecting with peers, investors, and strategic partners shaping the next generation of microbiome products
Leave With Insights On:
- Emerging business models driving success in today's microbiome market
- Investment trends influencing microbiome innovation
- Commercialization strategies that balance scientific innovation with long-term profitability
- The future of microbiome therapeutics, FMTs, and consumer health solutions
Accelerate the Journey from Microbiome Science to Clinical Impact
Advancing a microbiome programme from discovery through clinical development requires more than promising biology. Success depends on generating robust mechanistic evidence, translating scientific insights into clinical outcomes, and making the right development decisions at every stage of the journey.
At the 11th Microbiome Movement USA Summit, explore the scientific, translational, and clinical strategies helping organisations progress assets more efficiently, overcome development bottlenecks, and build stronger foundations for future regulatory and commercial success.
Who Should Attend?
- VP, Director & Head of Discovery
- VP, Director & Head of Preclinical Development
- VP, Director & Head of Translational Science
- VP, Director & Head of R&D
- VP, Director & Head of Clinical Development
Why Attend?
Explore how leading developers are:
- Translating advanced microbiome insights into therapeutic candidates that demonstrate clear clinical relevance
- Advancing programmes through Phase I, II, and pivotal studies to improve development efficiency and reduce program risk
- Expanding applications beyond gastrointestinal disease into oncology, women's health, neurology, and immune-mediated disorders
- Refining trial design and patient selection strategies to generate more meaningful clinical outcomes
- Bridging translational and clinical research to strengthen confidence in microbiome-driven mechanisms
- Leveraging lessons from validated programs to accelerate future development decisions
Leave With Insights On:
- New approaches to microbiome product design and development
- Translational strategies that strengthen clinical success
- Clinical data shaping the next generation of microbiome therapies
- Opportunities to apply microbiome science across emerging indications
Unlock Actionable Insights from Complex Microbiome Data
Generating microbiome data is no longer the bottleneck. The challenge now lies in transforming complex sequencing, biomarker, and multi-omic datasets into actionable insights that inform program decisions, strengthen mechanistic understanding, and support clinical success.
The 11th Microbiome Movement USA Summit provides a forum to explore the analytical, bioinformatic and biological approaches helping organisations uncover predictive biomarkers, better characterise patient response, and generate the evidence needed to advance microbiome programmes with greater confidence.
Who Should Attend?
- VP, Director & Head of Bioinformatics
- VP, Director & Head of Biology
- VP, Director & Head of Medical
- VP, Director & Head of Microbiology
- VP, Director & Head of Biomarkers
Why Attend?
Learn how innovators are:
- Applying advanced sequencing and analytics technologies to uncover clinically relevant microbiome insights
- Identifying biomarkers linked to treatment response to improve patient stratification and therapeutic performance
- Using bioinformatics to enhance mechanism-of-action understanding and support clinical decision-making
- Building stronger datasets from increasingly complex microbial ecosystems
- Integrating multi-omic approaches to unlock deeper biological understanding
- Generating evidence that supports regulatory, clinical, and commercial objectives
Leave With Insights On:
- Emerging biomarker strategies for microbiome programs
- Bioinformatics approaches improving translational success
- Novel methods for analysing complex microbiome datasets
- Data-driven opportunities to differentiate your program
Build Scalable, Compliant Microbiome Development Pathways
Successfully advancing microbiome therapies requires more than demonstrating clinical efficacy. Regulatory and CMC teams must establish scalable manufacturing processes, ensure product consistency, and build development programs capable of meeting evolving regulatory expectations.
The 11th Microbiome Movement USA Summit provides an opportunity to learn how leading organizations are navigating regulatory complexity, overcoming manufacturing challenges, and developing robust frameworks that support program progression from clinical development through to commercial readiness.
Who Should Attend?
- VP, Director & Head of Regulatory Affairs
- VP, Director & Head of Process Development
- VP, Director & Head of Manufacturing/MSAT
- VP, Director & Head of CMC
Why Attend?
Discover how organisations are:
- Navigating evolving regulatory expectations for microbiome-based therapies and live biotherapeutic products
- Addressing manufacturing scale-up challenges while maintaining product quality and consistency
- Reducing batch-to-batch variability to support clinical and commercial readiness
- Establishing robust CMC strategies that align with regulatory requirements and future market needs
- Preparing programs for later-stage development and commercialization
- Learning from organizations already advancing toward pivotal and commercial milestones
Leave With Insights On:
- Evolving FDA and global regulatory expectations
- Manufacturing strategies supporting program scalability
- Practical approaches to microbiome CMC development
- Quality frameworks for long-term commercial success
Learn Practical Solutions to Today's Microbiome Development Challenges
Progressing microbiome products requires more than scientific discovery alone. Research teams must generate reproducible data, validate biological mechanisms, and address the technical challenges that can impact program progression.
The 11th Microbiome Movement USA Summit brings together scientists working across discovery, clinical development and CMC to share practical lessons, emerging research, and proven strategies that can help accelerate development while reducing scientific and operational risk.
Who Should Attend?
- Principal Scientist
- Senior Scientist
- Scientist
- Associate Scientist
- Research Scientist
- Clinical Scientist
- CMC Scientist
Why Attend?
Learn how your peers are:
- Overcoming scientific and technical hurdles that impact program progression
- Applying new microbiome technologies and methodologies to strengthen development outcomes
- Characterizing microbial mechanisms more effectively to support therapeutic validation
- Supporting successful clinical translation through stronger preclinical evidence
- Building manufacturing-ready programs earlier in development
- Navigating a rapidly evolving microbiome ecosystem with greater confidence
Leave With Insights On:
- Cutting-edge microbiome science and technology
- New tools enabling program progression
- Successful development case studies from industry leaders
- Best practices for overcoming common development bottlenecks
Discover Where the Microbiome Industry Needs Support Most
Successfully advancing microbiome products requires expertise that many organizations cannot build entirely in-house. From sequencing and analytics to clinical development and manufacturing, developers are increasingly looking for specialist partners that can help accelerate program progression.
The 11th Microbiome Movement USA Summit provides solution providers with a focused opportunity to engage with the teams evaluating new technologies, outsourcing critical activities, and seeking partners to support the next generation of microbiome innovation.
Ideal Service Providers Include:
- Analytics Providers
- Sequencing Providers
- AI & Data Analysis Companies
- Preclinical CROs
- Clinical CROs
- CDMOs
- Reagent & Technology Providers
Connect With Decision-Makers Responsible For:
- Discovery & Research
- Preclinical Development
- Translational Science
- Clinical Development
- Bioinformatics & Data Science
- Medical & Microbiology
- Regulatory Affairs
- CMC & Manufacturing
- Executive Leadership
Why Get Involved?
Understand how microbiome innovators are:
- Seeking better analytical and sequencing capabilities to generate meaningful biological insights
- Scaling manufacturing processes to support clinical and commercial advancement
- Improving clinical execution and trial delivery through experienced development partners
- Leveraging AI and advanced analytics to accelerate decision-making and program optimization
- Reducing risk across development, manufacturing, and regulatory workflows
- Building strategic partnerships that help move promising microbiome products closer to patients and consumers
Leave With:
- A deeper understanding of the microbiome industry's most urgent challenges
- Direct access to senior decision-makers evaluating new partners
- Opportunities to showcase your expertise where demand is growing fastest
- Stronger commercial relationships across the microbiome ecosystem
Explore the 2026 Event Guide
- Join >80% C-level, VPs, and Directors to identify and connect with key opinion leaders in the microbiome space
- See the LBP and FMT coverage to pinpoint sessions most relevant to your program
- See active investors and strategic partners attending to refine your funding and partnering strategy
- Pharma insights from Ferring and ex-Takeda leaders to understand how to secure pharma support
- Learn from Vedanta, MRM Health, and AOBiome to overcome clinical setbacks and scale microbiome-based therapies
Explore the Agenda
Dive into real-world strategies tackling microbiome credibility, clinical efficacy, and regulatory hurdles so you can move your program forward with confidence.
Partner With Us
Position your solution at the centre of microbiome dealmaking as biotechs actively seek partners to validate, fund, and scale their programs.
Join Biopharma Experts
Connect with microbiome leaders across R&D, CMC, and BD to exchange insights, overcome shared challenges, and build partnerships that accelerate clinical and commercial success.